Volume 17, Issue 9, September 2015
Editorials
Brain tumor clinical trials imaging: a (well-standardized) picture is worth a thousand words
Neuro-Oncology, Volume 17, Issue 9, September 2015, Pages 1179–1180, https://doi.org/10.1093/neuonc/nov158
Blood-brain barrier-associated efflux transporters: a significant but underappreciated obstacle to drug development in glioblastoma
Neuro-Oncology, Volume 17, Issue 9, September 2015, Pages 1181–1182, https://doi.org/10.1093/neuonc/nov122
PI3K pathway inhibition in GBM—is there a signal?
Neuro-Oncology, Volume 17, Issue 9, September 2015, Pages 1183–1184, https://doi.org/10.1093/neuonc/nov124
Highlights from the Literature
Highlights from the Literature
Neuro-Oncology, Volume 17, Issue 9, September 2015, Pages 1185–1187, https://doi.org/10.1093/neuonc/nov161
Reviews
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
Neuro-Oncology, Volume 17, Issue 9, September 2015, Pages 1188–1198, https://doi.org/10.1093/neuonc/nov095
High-definition fiber tractography for the evaluation of perilesional white matter tracts in high-grade glioma surgery
Neuro-Oncology, Volume 17, Issue 9, September 2015, Pages 1199–1209, https://doi.org/10.1093/neuonc/nov113
Basic and Translational Investigations
Decreased affinity for efflux transporters increases brain penetrance and molecular targeting of a PI3K/mTOR inhibitor in a mouse model of glioblastoma
Neuro-Oncology, Volume 17, Issue 9, September 2015, Pages 1210–1219, https://doi.org/10.1093/neuonc/nov081
Ras-mediated modulation of pyruvate dehydrogenase activity regulates mitochondrial reserve capacity and contributes to glioblastoma tumorigenesis
Neuro-Oncology, Volume 17, Issue 9, September 2015, Pages 1220–1230, https://doi.org/10.1093/neuonc/nou369
Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis
Neuro-Oncology, Volume 17, Issue 9, September 2015, Pages 1231–1240, https://doi.org/10.1093/neuonc/nov010
Quantitative HER2 and p95HER2 levels in primary breast cancers and matched brain metastases
Neuro-Oncology, Volume 17, Issue 9, September 2015, Pages 1241–1249, https://doi.org/10.1093/neuonc/nov012
Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAs
Neuro-Oncology, Volume 17, Issue 9, September 2015, Pages 1250–1260, https://doi.org/10.1093/neuonc/nov014
CLINICAL INVESTIGATIONS
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K
Neuro-Oncology, Volume 17, Issue 9, September 2015, Pages 1261–1269, https://doi.org/10.1093/neuonc/nou328
Phase II study of PX-866 in recurrent glioblastoma
Neuro-Oncology, Volume 17, Issue 9, September 2015, Pages 1270–1274, https://doi.org/10.1093/neuonc/nou365
Phase I dose-escalation study of the PI3K/mTOR inhibitor voxtalisib (SAR245409, XL765) plus temozolomide with or without radiotherapy in patients with high-grade glioma
Neuro-Oncology, Volume 17, Issue 9, September 2015, Pages 1275–1283, https://doi.org/10.1093/neuonc/nov083
Neuroimaging
Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas
Neuro-Oncology, Volume 17, Issue 9, September 2015, Pages 1284–1292, https://doi.org/10.1093/neuonc/nov098
The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma
Neuro-Oncology, Volume 17, Issue 9, September 2015, Pages 1293–1300, https://doi.org/10.1093/neuonc/nov088
Letter to the Editor
Everolimus effectively blocks pulmonary metastases from meningioma
Neuro-Oncology, Volume 17, Issue 9, September 2015, Pages 1301–1302, https://doi.org/10.1093/neuonc/nov116
News and Announcements
Society news
Neuro-Oncology, Volume 17, Issue 9, September 2015, Page 1303, https://doi.org/10.1093/neuonc/nov160
Cover/Standing Material
Cover Page
Neuro-Oncology, Volume 17, Issue 9, September 2015, Page NP, https://doi.org/10.1093/neuonc/nov190
Editorial Board
Neuro-Oncology, Volume 17, Issue 9, September 2015, Page NP, https://doi.org/10.1093/neuonc/nov191
Subscription Page
Neuro-Oncology, Volume 17, Issue 9, September 2015, Page NP, https://doi.org/10.1093/neuonc/nov192
Contents Page
Neuro-Oncology, Volume 17, Issue 9, September 2015, Page NP, https://doi.org/10.1093/neuonc/nov193
